Inventor · disambiguated record
Mahmoud Ameri
Also filed as: AMERI MAHMOUD
16 granted patents·20 pending applications·168 citations·filing 2003–2023
93Inventor score
Top patents by PatentIndex Score
36 records- 0196US7556821B2Apparatus and method for transdermal delivery of parathyroid hormone agentsALZA CORP·Filed 2005·Granted Jul 7, 2009·48 cites·2 claims
- 0293US8632801B2Stable therapeutic formulationsAMERI MAHMOUD·Filed 2006·Granted Jan 21, 2014·14 cites·21 claims
- 0393US8361022B2Apparatus for transdermal delivery of parathyroid hormone agentsALZA CORP·Filed 2009·Granted Jan 29, 2013·28 cites·76 claims
- 0491US8920817B2Formulations for coated microprojections containing non-volatile counterionsAMERI MAHMOUD·Filed 2009·Granted Dec 30, 2014·21 cites·22 claims
- 0590US9918932B2Method of rapidly achieving therapeutic concentrations of triptans for treatment of migrainesZP OPCO INC·Filed 2017·Granted Mar 20, 2018·5 cites·42 claims
- 0689US9782344B2Stable glucagon peptide formulationsZP OPCO INC·Filed 2015·Granted Oct 10, 2017·4 cites·29 claims
- 0788US9295714B2Apparatus and method for transdermal delivery of parathyroid hormone agentsAMERI MAHMOUD·Filed 2009·Granted Mar 29, 2016·10 cites·10 claims
- 0887US8633159B2Apparatus and method for transdermal delivery of parathyroid hormone agentsAMERI MAHMOUD·Filed 2010·Granted Jan 21, 2014·10 cites·13 claims
- 0986US9573717B2Stable therapeutic formulationsALZA CORP·Filed 2014·Granted Feb 21, 2017·3 cites·11 claims
- 1085US7579013B2Formulations for coated microprojections containing non-volatile counterionsALZA CORP·Filed 2004·Granted Aug 25, 2009·19 cites·15 claims
- 1184US11058630B2Method of rapidly achieving therapeutic concentrations of triptans for treatment of migrainesZOSANO PHARMA CORP·Filed 2018·Granted Jul 13, 2021·3 cites·36 claims
- 1281US9173924B2Stable glucagon peptide formulationsZP OPCO INC·Filed 2014·Granted Nov 3, 2015·2 cites·45 claims
- 1378US11179324B2Stable therapeutic formulationsALZA CORP·Filed 2017·Granted Nov 23, 2021·1 cites·23 claims
- 1471US2022133627A1Stable Therapeutic FormulationsALZA CORP·Filed 2021·Application pending·0 cites
- 1565US11839683B2Method of rapidly achieving therapeutic concentrations of triptans for treatment of migrainesEMERGEX USA CORP·Filed 2021·Granted Dec 12, 2023·0 cites·15 claims
- 1662US2006275170A1Method for terminal sterilization of transdermal delivery devicesAMERI MAHMOUD·Filed 2006·Application pending·0 cites
- 1761US2009117158A1Transdermal sustained release drug deliveryAMERI MAHMOUD·Filed 2008·Application pending·0 cites
- 1861US2009136554A1Transdermal sustained release drug deliveryALZA CORP·Filed 2008·Application pending·0 cites
- 1956US11660265B2Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headachesZP OPCO INC·Filed 2019·Granted May 30, 2023·0 cites·21 claims
- 2056US2023255881A1Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headachesEMERGEX USA CORP·Filed 2023·Application pending·0 cites
- 2156US2005090009A1Compositions of stabilized DNA for coating microprojctionsFiled 2004·Application pending·0 cites
- 2256US2018153798A1Stable Glucagon Peptide FormulationsZP OPCO INC·Filed 2017·Application pending·0 cites
- 2356US2005106209A1Composition and apparatus for transdermal deliveryFiled 2004·Application pending·0 cites
- 2453US2006182789A1Apparatus and method for transdermal delivery of epoetin-based agentsAMERI MAHMOUD·Filed 2006·Application pending·0 cites
- 2549US2005266011A1Method and formulation for transdermal delivery of immunologically active agentsMAA YUH-FUN·Filed 2005·Application pending·0 cites
- 2649US2024181036A1Transdermal active agent delivery devices having coronavirus vaccine coated micro-protrusionsEMERGEX USA CORP·Filed 2021·Application pending·0 cites
- 2748US2006177494A1Coated microprojections having reduced variability and method for producing sameCORMIER MICHEAL·Filed 2006·Application pending·0 cites
- 2848US2023210762A1Transdermal drug delivery devices having psilocybin, lysergic acid diethylamide or 3,4-methylenedioxymethamphetamine coated microprotrusionsEMERGEX USA CORP·Filed 2021·Application pending·0 cites
- 2946US11660264B2Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headachesZP OPCO INC·Filed 2018·Granted May 30, 2023·0 cites·23 claims
- 3046US2008039775A1Apparatus and Method for Transdermal Delivery of Parathyroid Hormone Agents to Prevent or Treat OsteopeniaALZA CORP·Filed 2007·Application pending·0 cites
- 3143US2004062813A1Transdermal drug delivery devices having coated microprotrusionsFiled 2003·Application pending·0 cites
- 3242US2006188555A1Therapeutic peptide formulations with improved stabilityCORMIER MICHEAL·Filed 2006·Application pending·0 cites
- 3342US2006040864A1Apparatus and method for transdermal delivery of vascular endothelial growth factorsAMERI MAHMOUD·Filed 2005·Application pending·0 cites
- 3442US2005123507A1Formulations for coated microprojections having controlled solubilityFiled 2005·Application pending·0 cites
- 3541US2005226922A1Apparatus and method for transdermal delivery of fentanyl-based agentsAMERI MAHMOUD·Filed 2005·Application pending·0 cites
- 3640US2022057377A1Analytical method for determination of in vitro drug release profile from microneedle patchesZOSANO PHARMA CORP·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mahmoud Ameri files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →